These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 214073)

  • 21. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.
    Wallace AV; Heyworth CM; Houslay MD
    Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic nucleotides in disease; on the biochemical etiology of hypertension.
    Amer MS
    Life Sci; 1975 Oct; 17(7):1021-38. PubMed ID: 172752
    [No Abstract]   [Full Text] [Related]  

  • 23. Type III cyclic nucleotide phosphodiesterases and insulin action.
    Manganiello VC; Degerman E; Taira M; Kono T; Belfrage P
    Curr Top Cell Regul; 1996; 34():63-100. PubMed ID: 8646851
    [No Abstract]   [Full Text] [Related]  

  • 24. Uncoupling of the glucagon receptor-adenylate cyclase system by glucagon in cloned differentiated rat hepatocytes.
    Reilly T; Beckner S; Blecher M
    J Recept Res; 1980; 1(2):277-311. PubMed ID: 6271954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does insulin exert certain of its actions through a distinct species of guanine nucleotide regulatory protein?
    Houslay MD; Wallace AV; Cooper ME; Payne NJ; Wilson SR; Heyworth CM
    Biochem Soc Trans; 1984 Oct; 12(5):766-8. PubMed ID: 6094281
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin controls intracellular cyclic AMP concentrations in hepatocytes by activating specific cyclic AMP phosphodiesterases: phosphorylation of the peripheral plasma membrane enzyme.
    Houslay MD; Wallace AV; Marchmont RJ; Martin BR; Heyworth CM
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():159-76. PubMed ID: 6326521
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of in vitro PUVA treatment on adenylate cyclase responses of epidermis.
    Kajita S; Iizuka H
    J Dermatol; 1987 Apr; 14(2):132-6. PubMed ID: 2440931
    [No Abstract]   [Full Text] [Related]  

  • 28. Morphology and cyclic AMP metabolism of normal and spontaneously transformed rabbit transitional epithelium in vitro.
    Chlapowski FJ
    Life Sci; 1978 Oct; 23(13):1325-36. PubMed ID: 214646
    [No Abstract]   [Full Text] [Related]  

  • 29. Simulations of the roles of multiple cyclic nucleotide phosphodiesterases.
    Reynolds CH
    Biochem J; 1982 Jan; 202(1):125-32. PubMed ID: 6282269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concerning cyclic AMP.
    Moses V
    Sci Prog; 1976; 63(252):503-20. PubMed ID: 184526
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of chlorpropamide and phenformin on rat liver: the effect on plasma membrane-bound enzymes and cyclic AMP content of hepatocytes in vitro.
    Luly P; Baldini P; Cocco C; Incerpi S; Tria E
    Eur J Pharmacol; 1977 Nov; 46(2):153-64. PubMed ID: 201470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cyclic AMP in insulin release.
    Malaisse WJ; Malaisse-Lagae F
    Experientia; 1984 Oct; 40(10):1068-74. PubMed ID: 6092126
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclic AMP and cyclic GMP in epidermal physiology and pathophysiology.
    Voorhees JJ; Duell EA; Creehan P; Stawiski M; Harrell ER
    Curr Probl Dermatol; 1976; 6():107-53. PubMed ID: 8278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cAMP and regulation of carbohydrate metabolism.
    Botsford JL
    Basic Life Sci; 1981; 18():315-34. PubMed ID: 6268054
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B; Luong HB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid changes in the activities of the enzymes of cyclic AMP metabolism after addition of A23187 to macrophages.
    Lim LM; Hunt NH; Evans T; Weidemann MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(2):745-50. PubMed ID: 6277316
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fluctuations in the level of cyclic AMP and activities of adenylate cyclase and cyclic-AMP phosphodiesterase in synchronous cultures of the prokaryote Nocardia restricta (author's transl)].
    Lefebvre G; Martin N; Schneider F; Raval G; Gay R
    Biochim Biophys Acta; 1978 May; 540(2):221-30. PubMed ID: 207351
    [No Abstract]   [Full Text] [Related]  

  • 39. Postnatal development of glycogen- and cyclic AMP-metabolizing enzymes in mammalian skeletal muscle.
    Smith PB
    Biochim Biophys Acta; 1980 Feb; 628(1):19-25. PubMed ID: 6243998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responsiveness to glucagon by isolated rat hepatocytes controlled by the redox state of the cytosolic nicotinamide--adenine dinucleotide couple acting on adenosine 3':5'-cyclic monophosphate phosphodiesterase.
    Clark MG; Jarrett IG
    Biochem J; 1978 Dec; 176(3):805-16. PubMed ID: 218554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.